Lynn A. Tetrault - 11 Oct 2021 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Director
Signature
Lynn A. Tetrault
Issuer symbol
NEO
Transactions as of
11 Oct 2021
Net transactions value
$0
Form type
4
Filing time
13 Oct 2021, 17:04:44 UTC
Previous filing
14 Jun 2021
Next filing
20 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Award $0 +838 +2.4% $0.000000 35,777 11 Oct 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEO Stock Option (Right to Buy) Award $0 +972 $0.000000 972 11 Oct 2021 Common Stock 972 $41.76 Direct
holding NEO Stock Option (Right to Buy) 3,334 11 Oct 2021 Common Stock 3,334 $7.27 Direct F1
holding NEO Stock Option (Right to Buy) 1,507 11 Oct 2021 Common Stock 1,507 $11.60 Direct
holding NEO Stock Option (Right to Buy) 2,136 11 Oct 2021 Common Stock 2,136 $22.52 Direct
holding NEO Stock Option (Right to Buy) 3,448 11 Oct 2021 Common Stock 3,448 $28.54 Direct
holding NEO Stock Option (Right to Buy) 3,714 11 Oct 2021 Common Stock 3,714 $40.90 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 25, 2017, Lynn Tetrault was granted 10,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.